Air trapping: The major factor limiting diaphragm mobility in chronic obstructive pulmonary disease patients

医学 慢性阻塞性肺病 振膜(声学) 空气滞留 肺功能测试 心脏病学 动态恶性通货膨胀 内科学 恶性通货膨胀 肺容积 呼吸系统 气道阻塞 气道 麻醉 扬声器 经济 货币政策 物理 货币经济学 声学
作者
Wellington Pereira Yamaguti,Elaine Paulin,Simone Shibao,Maria Cristina Chammas,João Marcos Salge,Marcos Ribeiro,Alberto Cukier,Celso Ricardo Fernandes Carvalho
出处
期刊:Respirology [Wiley]
卷期号:13 (1): 138-144 被引量:112
标识
DOI:10.1111/j.1440-1843.2007.01194.x
摘要

Background and objective: Patients with COPD can have impaired diaphragm mechanics. A new method of assessing the mobility of the diaphragm, using ultrasound, has recently been validated. This study evaluated the relationship between pulmonary function and diaphragm mobility, as well as that between respiratory muscle strength and diaphragm mobility, in COPD patients. Methods: COPD patients with pulmonary hyperinflation ( n = 54) and healthy subjects ( n = 20) were studied. Patients were tested for pulmonary function, maximal respiratory pressures and diaphragm mobility using ultrasound to measure the craniocaudal displacement of the left branch of the portal vein. Results: COPD patients had less diaphragm mobility than did healthy individuals (36.5 ± 10.9 mm vs 46.3 ± 9.5 mm, P = 0.001). In COPD patients, diaphragm mobility correlated strongly with pulmonary function parameters that quantify air trapping (RV: r = −0.60, P < 0.001; RV/TLC: r = −0.76, P < 0.001), moderately with airway obstruction (FEV 1 : r = 0.55, P < 0.001; airway resistance: r = −0.32, P = 0.02) and weakly with pulmonary hyperinflation (TLC: r = −0.28, P = 0.04). No relationship was observed between diaphragm mobility and respiratory muscle strength (maximal inspiratory pressure: r = −0.11, P = 0.43; maximal expiratory pressure: r = 0.03, P = 0.80). Conclusion: The results of this study suggest that the reduction in diaphragm mobility in COPD patients is mainly due to air trapping and is not influenced by respiratory muscle strength or pulmonary hyperinflation.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
paper1完成签到,获得积分10
刚刚
CFD应助阳佟怀绿采纳,获得10
刚刚
1秒前
1秒前
1秒前
1秒前
XMC2022发布了新的文献求助30
2秒前
活力的惜萱完成签到,获得积分10
2秒前
2秒前
脑洞疼应助heee采纳,获得10
2秒前
yangyang发布了新的文献求助10
3秒前
帅气的小兔子完成签到 ,获得积分10
4秒前
Apricity完成签到,获得积分10
4秒前
OK发布了新的文献求助10
4秒前
wanshishengyi完成签到,获得积分20
4秒前
aphelion完成签到,获得积分10
4秒前
丘比特应助复杂明辉采纳,获得10
5秒前
勇敢的蝙蝠侠完成签到 ,获得积分10
5秒前
5秒前
耍酷的枇杷完成签到,获得积分10
6秒前
忧郁的白风完成签到 ,获得积分10
6秒前
czm完成签到,获得积分10
6秒前
6秒前
7秒前
wxyshare给qutt的求助进行了留言
7秒前
7秒前
江舁完成签到 ,获得积分10
7秒前
八万完成签到,获得积分10
7秒前
paper1发布了新的文献求助10
8秒前
852应助Superan采纳,获得10
8秒前
8秒前
源源发布了新的文献求助10
8秒前
舟舟完成签到 ,获得积分10
8秒前
优秀含羞草完成签到,获得积分10
9秒前
Truman完成签到,获得积分10
9秒前
9秒前
zhouleiwang完成签到,获得积分10
9秒前
隐形曼青应助鲸鱼采纳,获得10
10秒前
李暴龙完成签到,获得积分10
10秒前
生动新蕾完成签到 ,获得积分10
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Prompt Engineering for Clinicians: Harnessing AI in Everyday Medical Practice 600
University Physics for the Life Sciences 500
REAL-WORLD EFFICACY AND GENOMIC LANDSCAPE OF POLATUZUMA VEDOTIN-BASED FIRST-LINE THERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA: A FOCUS ON TP53 MUTATIONS AND TREATMENT RESPONSE 500
Handbook of Luminescence Dating 500
Safety Pharmacology 500
《KNN基无铅压电陶瓷电学性能优化与物理机理研究》 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 计算机科学 化学工程 生物化学 物理 内科学 复合材料 催化作用 光电子学 物理化学 电极 细胞生物学 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6952833
求助须知:如何正确求助?哪些是违规求助? 8636832
关于积分的说明 18314365
捐赠科研通 6396113
什么是DOI,文献DOI怎么找? 3082545
关于科研通互助平台的介绍 2128236
邀请新用户注册赠送积分活动 2059406